Lineage Cell Therapeutics, Inc.
LCTX
$1.23
$0.010.82%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.38M | 55.78M | 40.49M | 42.29M | 47.91M |
| Total Receivables | 2.20M | 1.56M | 127.00K | 256.00K | 213.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.35M | 1.79M | 1.62M | 1.28M | 1.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.50K | 22.50K | 22.50K | 17.90K | 17.90K |
| Total Current Assets | 56.16M | 59.16M | 42.26M | 43.84M | 49.98M |
|
|
|||||
| Total Current Assets | 56.16M | 59.16M | 42.26M | 43.84M | 49.98M |
| Net Property, Plant & Equipment | 4.62M | 4.70M | 4.47M | 4.07M | 4.05M |
| Long-term Investments | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M |
| Goodwill | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M |
| Total Other Intangibles | 31.70M | 31.70M | 31.70M | 31.70M | 46.54M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.37M | 6.36M | 539.00K | 511.00K | 504.00K |
| Total Assets | 109.53M | 112.58M | 89.64M | 90.80M | 111.75M |
|
|
|||||
| Total Accounts Payable | 7.16M | 2.34M | 1.52M | 1.50M | 2.00M |
| Total Accrued Expenses | 3.98M | 4.84M | 3.03M | 2.95M | 2.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 865.00K | 853.00K | 1.07M | 1.05M | 1.18M |
| Total Finance Division Other Current Liabilities | 1.72M | 3.33M | 3.77M | 5.26M | 6.93M |
| Total Other Current Liabilities | 1.72M | 3.33M | 3.77M | 5.26M | 6.93M |
| Total Current Liabilities | 8.15M | 11.37M | 9.38M | 10.76M | 13.09M |
|
|
|||||
| Total Current Liabilities | 8.15M | 11.37M | 9.38M | 10.76M | 13.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.53M | 1.57M | 1.56M | 1.11M | 1.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 47.16M | 56.31M | 57.91M | 31.83M | 19.95M |
| Total Liabilities | 56.84M | 69.24M | 68.84M | 43.69M | 34.10M |
|
|
|||||
| Common Stock & APIC | 529.66M | 515.47M | 494.18M | 490.55M | 489.31M |
| Retained Earnings | -471.81M | -467.00M | -467.85M | -438.07M | -407.60M |
| Treasury Stock & Other | -3.97M | -3.92M | -4.29M | -4.10M | -2.68M |
| Total Common Equity | 53.88M | 44.55M | 22.04M | 48.39M | 79.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 53.88M | 44.55M | 22.04M | 48.39M | 79.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.18M | -1.20M | -1.24M | -1.27M | -1.37M |
| Total Equity | 52.70M | 43.35M | 20.80M | 47.11M | 77.66M |
|
|
|||||